Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2L9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,417
Award facts
- Contract value 100% obligated
- $26,416.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,416.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pens on January 14, 2026, with completion scheduled for January 15, 2026. This non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
Zepbound is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries to federal agencies supporting military treatment facilities and veterans' healthcare programs. As a major pharmaceutical distributor, the company regularly competes on a full and open basis for such procurement requirements, demonstrating its capability to meet federal medical supply demands across multiple therapeutic domains. The award reflects the ongoing reliance by the Department of Defense on commercial pharmaceutical distribution partners to supply critical medications necessary for military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FA2L9?
SPE2DR26FA2L9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FA2L9 worth?
The government has obligated $26,417 on SPE2DR26FA2L9.
Is contract SPE2DR26FA2L9 an order under another contract?
Yes. SPE2DR26FA2L9 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2L9 competed?
The extent of competition for SPE2DR26FA2L9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award